BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8369040)

  • 1. Chelation treatment of neurological Wilson's disease.
    Walshe JM; Yealland M
    Q J Med; 1993 Mar; 86(3):197-204. PubMed ID: 8369040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients.
    Walshe JM
    Q J Med; 1989 Mar; 70(263):253-63. PubMed ID: 2602537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
    Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
    Haslam RH; Sass-Kortsak A; Stout W; Berg M
    Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S; Taly AB
    J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
    Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
    QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
    Scheinberg IH; Jaffe ME; Sternlieb I
    N Engl J Med; 1987 Jul; 317(4):209-13. PubMed ID: 3600712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Wilson's disease: physiopathology, therapeutic approach and case report].
    Gallo V; Riva P; Sidoli L; Bisbocci D
    Minerva Gastroenterol Dietol; 1994 Dec; 40(4):197-201. PubMed ID: 7849148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of Wilson disease].
    Smolarek C; Stremmel W
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological abnormalities in Wilson's disease are reversible.
    Lingam S; Wilson J; Nazer H; Mowat AP
    Neuropediatrics; 1987 Feb; 18(1):11-2. PubMed ID: 3561699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wilson's disease--critical deterioration under high-dose parenteral penicillamine therapy].
    Hilz MJ; Druschky KF; Bauer J; Neundörfer B; Schuierer G
    Dtsch Med Wochenschr; 1990 Jan; 115(3):93-7. PubMed ID: 2298126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of treatment of Wilson's disease--own observations.
    Jabłońska-Kaszewska I; Drobińska-Jurowiecka A; Dabrowska E; Trocha H
    Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Wilson's disease].
    Kovacević I; Zekan M
    Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Wilson's disease.
    Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
    Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
    [No Abstract]   [Full Text] [Related]  

  • 20. Wilson's disease in Eastern India.
    Sinha S; Jha DK; Sinha KK
    J Assoc Physicians India; 2001 Sep; 49():881-4. PubMed ID: 11837754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.